Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Oxygenation index as a respiratory parameter of respiratory distress syndrome in preterm infants

미숙아 호흡 곤란 증후군에서 호흡 중증도 지표로서의 oxygenation index

  • Jeon, Ji Hyun (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Namgung, Ran (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Park, Min Soo (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Park, Kook In (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Lee, Chul (Department of Pediatrics, Yonsei University College of Medicine)
  • 전지현 (연세대학교 의과대학 소아과학교실) ;
  • 남궁란 (연세대학교 의과대학 소아과학교실) ;
  • 박민수 (연세대학교 의과대학 소아과학교실) ;
  • 박국인 (연세대학교 의과대학 소아과학교실) ;
  • 이철 (연세대학교 의과대학 소아과학교실)
  • Received : 2007.12.15
  • Accepted : 2008.01.19
  • Published : 2008.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : To examine whether changes of oxygenation index (OI) by postnatal age were different by the number of surfactant administration, and different between subgroups of survival and death. Methods : From January 2005 to June 2006, preterm infants (n=84) diagnosed as respiratory distress syndrome (RDS) and treated with surfactant and ventilator were included. They were divided into two groups: Group I (n=54) was infants received surfactant, one time and Group II (n=30) was infants received surfactant, two times. We also categorized group I & II infants into two subgroups in each group: survival group and death group. We calculated OI at birth, 24 hr, 48 hr and 72 hr after birth. Results : Gestational age ($30.1{\pm}2.6wk\;vs\;28.4{\pm}3.4wk$) and birth weight ($1,478{\pm}442g\;vs\;1,199{\pm}495g$) were different between group I and group II. In preterm infants with RDS, the changes of OI by postnatal age were different between groups (P=0.001) and different with time change (P<0.001). In group I, the OI of survival subgroup showed decreasing by postnatal age compared with death subgroup, but was not significantly different between subgroups. In group II, the change of OI was not different between survival and death. Conclusion : These findings suggest that OI helps to predict the respiratory condition in preterm infants with RDS.

목 적 : OI가 폐의 중증도를 반영한다는 가정 하에 미숙아 호흡 곤란 증후군에서 표면활성제 투여 횟수 및 생존, 사망에 따라 OI가 어떠한 차이가 있는지 연구하고자 하였다. 방 법 : 2005년 1월부터 2006년 6월까지 세브란스 어린이병원 신생아 중환자실에 내원한 미숙아 84명을 대상으로 출생 시, 생후 24시간째, 48시간째, 72시간째 OI를 구하였다. 환아 들을 표면활성제 1회 투여 군을 Group I, 표면활성제 2회 투여 군을 Group II로 분류하였고, 각 군에서 생존, 사망으로 아 분류하여 비교 분석하였다. 결 과 : Group I(n=54)과 Group II(n=30)은 재태주령($30.1{\pm}2.6wk\;vs\;28.4{\pm}3.4wk$)과 출생체중($1,478{\pm}442g\;vs\;1,199{\pm}495g$)이 유의한 차이를 보였고(P=0.027 vs 0.013), Group I의 사망이 2명, Group II의 사망이 9명으로 유의한 차이를 보였다(P=0.001). 생후 나이에 따른 OI 변화는 군 간의 차이를 보였고(P=0.001), 시간의 변화에 따라 유의한 감소를 보였다(P<0.001). Group I에서 생존군(n=52)과 사망군(n=2)의 OI 변화는 차이가 없었으며, 시간의 변화에 따른 차이도 없었다. Group II에서도 생존 군(n=21)과 사망 군(n=9)간의 OI 변화와 생후 나이에 따른 OI 변화는 유의한 차이가 없었다. 결 론 : 미숙아 RDS 환아에 있어서, OI는 표면활성제 1회 및 2회투여 군 간에 유의한 차이를 보였고, 생후 나이에 따라 유의한 감소가 있었다. Group II에서 사망 군의 OI는 감소하지 않았다. OI는 RDS 환아의 폐 중증도를 파악하는데, 유용한 지표로 생각되며, 추 후 더 많은 환자군을 대상으로한 연구가 필요할 것으로 사료된다.

Keywords

References

  1. Beydoun H, Yuins KA, Khogali M, Usta I, Tamin H; Neonatal Collaborative Perinatal Neonatal Network. Caesarean route of delivery and Hyaline membrane disease: a hospital-based case-control study in greater Berut. Paediatr Perinat Epidermiol 2003;17:363-8 https://doi.org/10.1046/j.1365-3016.2003.00518.x
  2. Bartlett RH, Gazzaniga AB, Toomasian J, Coran AG, Roloff D, Rucker R, et al. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg 1986;204:236-46 https://doi.org/10.1097/00000658-198609000-00003
  3. Khambekar K, Nichani S, Luyt DK, Peek G, Firmin RK, Field DJ, et al. Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation:present experience. Arch Dis Child Fetal Neonatal Ed. 2006;91:F21-5 https://doi.org/10.1136/adc.2004.066290
  4. Kossel H, Bauer K, Kewitz G, Karaca S, Versmold H. Do we need new indications for ECMO in neonates pretreated with high frequency ventilation and/or inhaled nitric oxide? Intensive Care Med 2000;26:1489-95 https://doi.org/10.1007/s001340000603
  5. Khan N, Brown A, Venkataraman ST. Predictors of extubation success and failure in mechanically ventilated infants and children. Crit Care Med 1996;24;1568-79 https://doi.org/10.1097/00003246-199609000-00023
  6. Trachsel D, Mccrindle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2005;172:206-11 https://doi.org/10.1164/rccm.200405-625OC
  7. Dynio H, Ann RS. Respiratory distress syndrome. In: John PC, Eric CE, Ann RS. Manual of neonatal care. 4th ed. Philadelphia: Lippincott williams and wilkins 2006:341-8
  8. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517-23
  9. Lynch RG. Surfactant and RDS in premature infants. FASEBJ 2004;18:1624 https://doi.org/10.1096/fj.04-2077bkt
  10. Hamvas A, Wise PH, Yang RK, Wampler NS, Noguchi A, Maurer NM, et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med 1996;334:1635-40 https://doi.org/10.1056/NEJM199606203342504
  11. Hoekstra RE, Ferrara TB, Payne NR. Effects of surfactant therapy on outcome of extremely premature infants. Eur J Pediatr 1994;153(9 Suppl 2):S12-6 https://doi.org/10.1007/BF02179667
  12. Horbar JD, Wright EC, Onstad I. Decreasing mortality associated with the introdution of surfactant therapy: an observational study of neonates weighting 601 to 1,300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network. Pediatrics 1993;92:191-6
  13. Lee K, Khoshnood B, Wall SN, Chang Y, Hsieh HL, Singh JK. Trend in mortality from respiratory distress syndrome in the United States, 1970-1995. J Pediatr 1999;134:434-40 https://doi.org/10.1016/S0022-3476(99)70200-3
  14. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. New Eng J Med 1994;330:1476-80 https://doi.org/10.1056/NEJM199405263302102
  15. Suresh GK, Soll RF. Overview of surfactant replacement trials. J perinatol 2005;25:40S-4S https://doi.org/10.1038/sj.jp.7211320
  16. Doyle LW, Gultom E, Chuang SL, James M, Davis P, Bowman E. Changing mortality and causes of death in infants 23-27 weeks' gestational age. J Pediatr Child Health 1999;35:255-9 https://doi.org/10.1046/j.1440-1754.1999.00349.x
  17. Dhanireddy S, Altemeier WA, Matute-Bello G, O'Hahony DS, Glenny RW, Martin TR, et al. Mechanical ventilation induces inflammation, respiratory injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab invest 2006;86:790-9 https://doi.org/10.1038/labinvest.3700440
  18. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Resp Crit Care Med 2002;165:867-903 https://doi.org/10.1164/ajrccm.165.7.2105078
  19. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-8 https://doi.org/10.1164/ajrccm/142.3.523
  20. Lefering R, Goris RJ, Nieuwenhoven EJ, Neugebauer E. Revision of the multiple organ failure score. Langenbecks Arch Surg 2002;387:14-20 https://doi.org/10.1007/s00423-001-0269-3
  21. Vincent JL, Sakr Y, Ranieri VM. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med 2003;31:S296-9 https://doi.org/10.1097/01.CCM.0000057906.89552.8F
  22. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003;289:2104-12 https://doi.org/10.1001/jama.289.16.2104
  23. Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med 1991;324:1445-50 https://doi.org/10.1056/NEJM199105233242101
  24. Jabour ER, Rabil DM, Truwit JD, Rochester DF. Evaluation of new weaning index based on ventilatory endurance and the efficiency of gas exchange. Am Rev Respir Dis 1991:144:531-7 https://doi.org/10.1164/ajrccm/144.3_Pt_1.531

Cited by

  1. The Effect on Pulmonary Indices of Surfactant Therapy for Meconium Aspiration Syndrome: Systematic Review and Meta-analysis vol.18, pp.2, 2008, https://doi.org/10.5385/jksn.2011.18.2.189